Publicly Traded Hospice Companies Poised for Deals

The nation’s publicly traded hospice companies are primed for more acquisitions after a 2023 slump, fueled by census and growth. Transaction volume declined in the hospice and home-based care space in 2023, following the two record-breaking prior years. Many expect a rebound in 2024, and stirrings in the public company space signal that may come […]

Hospice Provider BrightSpring Begins Trading on NASDAQ

BrightSpring Health Services, Inc. has begun trading on the NASDAQ under the stock symbol BTSG. BrightSpring is a home- and community-based health care services platform that serves more than 400,000 patients daily. The company indicated its intent to go public in a Jan. 3 filing with the U.S. Securities and Exchange Commission, expecting a $1 […]

BrightSpring Refiles to Go Public, Zeros in on $1 Billion Goal

Nearly a year after shying away from becoming an initial public offering (IPO), BrightSpring Health Services Inc. has allegedly re-filed, this time with a much higher valuation. The company, which does not yet have a stock symbol, raised the bar from when it initially filed in October 2021 with a $100 million listing. BrightSpring later […]

Home Health, Personal Care Reimbursement Guiding Addus’ M&A Strategy

As Addus HomeCare Corporation (NASDAQ: ADUS) sinks teeth into acquisitions, the company will be taking smaller bites when it comes to hospice deals. Addus has indicated for roughly the last year that it will orient its M&A strategy towards its home health and personal care services, with hospice becoming less of a priority. But this […]

5 Game-Changing Hospice Deals from 2022

Though hospice deal volume dipped in 2022 compared to previous years, five particular transactions could paint a larger picture of where investors see value in the space. These interesting, unusual or groundbreaking deals could signal what’s to come in 2023 and help shape the hospice market’s long-term future. Optum to pick up LHC Group Though […]

Amedisys ‘On the Hunt’ for Deals, with PE Firms as Top M&A Competitors

Private equity (PE) firms represent the strongest competitors for strategic buyers in the hospice mergers-and-acquisitions market.  Hospice M&A activity cooled off across the board during the first quarter of 2022. In part, this is because a range of buyers scrambled to complete deals during late 2021 and are now focused on integrating those assets. But […]

The Thought Process Behind Humana’s Kindred at Home Transactions

In its calculus behind its 2021 Kindred at Home deal, Humana Inc. (NYSE: HUM) had to weigh the potential cost savings and lucrative hospice divestiture against the labor pressures in the space, as well as the complexity of scaling home-based care in a fragmented industry. Last year, Humana acquired total ownership of Kindred at Home […]

LHC Group Stays Bullish on Hospice Expansion

Home health and hospice provider LHC Group (NASDAQ: LHCG) is determined to cast a larger shadow on the hospice space this year and next, largely through acquisitions with joint venture partners. The company last December voiced its intention to double its hospice footprint nationally within 12 to 18 months, with a focus on co-locating hospice […]